Zohreh Mirjafary

Dr. Zohreh Mirjafary


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
MAMorteza Abdoli
Morteza Abdoli
ZMZohreh Mirjafary
Zohreh Mirjafary
HSHamid Saeidian
Hamid Saeidian
AKAli Kakanejadifard
Ali Kakanejadifard
Purine bases have attracted much attention due to their potential biological activities. Developing more efficient methods for the modification of purine bases with a substitution such as aryl or alkyl is particularly interesting. This review gives an overview of new developments in direct functionalization of C–H and N–H bonds of purine bases via metal catalyzed cross-coupling reactions in recent years.

5 February 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
ZMZohreh Mirjafary
Zohreh Mirjafary
MAMorteza Abdoli
Morteza Abdoli
HSHamid Saeidian
Hamid Saeidian
AKAli Kakanejadifard
Ali Kakanejadifard
SFS. Morteza F. Farnia
S. Morteza F. Farnia
Oxime ethers have attracted much attention due to their potential biological activities and wide variety of synthetic applications. Developing more efficient methods for the synthesis of oxime ethers has been the subject of numerous of papers in recent years. This review surveys literature methods for the synthesis of acyclic and cyclic oxime ethers.

8 September 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
ZMZohreh Mirjafary
Zohreh Mirjafary
LALeila Ahmadi
Leila Ahmadi
MMMasomeh Moradi
Masomeh Moradi
HSHamid Saeidian
Hamid Saeidian
An efficient and practical synthesis of 1,4-disubstituted-1,2,3-triazoles under click conditions using a copper(II)–thioamide combination as an efficient heterogeneous catalyst is disclosed. Mild reaction conditions and high yields make this method an attractive option for the preparation of triazole derivatives. The key to this procedure was the generation of Cu(I) required for the azide-alkyne cycloaddition, which was achieved by in situ reduction of Cu(II) using thiobenzanilide as reduction agent and ligand.

17 December 2020 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
PDF file
FGFarideh Godarzbod
Farideh Godarzbod
ZMZohreh Mirjafary
Zohreh Mirjafary
Hamid SaeidianHamid Saeidian
Hamid Saeidian
MRMorteza Rouhani
Morteza Rouhani

9 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RSRasoul Shahbazi
Rasoul Shahbazi
ZMZohreh Mirjafary
Zohreh Mirjafary
NZNosratollah Zarghami
Nosratollah Zarghami
HSHamid Saeidian
Hamid Saeidian
Two strategies were employed to modify the performance of the nano-niosome drug delivery system. Initially, the surface of the nano-niosomes underwent modification through the inclusion of polyethylene glycol, thereby altering its properties. Additionally, the core of the nano-niosomes was equipped with Fe3O4 magnetic nanoparticles to impart magnetic characteristics to the system. This study presents the development of PEGylated magnetic nanoniosomes (PMNios) for the co-delivery of artemisinin (ART) and metformin (MET) in cancer therapy, highlighting significant advancements in chemotherapeutic efficacy. The magnetization of the nano-niosomes facilitated the targeted delivery of drugs to specific tissues, while PEGylation improved the bioavailability of the nano-niosomes. These PEGylated magnetic niosomes (PMNios) were then loaded with artemisinin and metformin drugs. The synthesized PMNios were thoroughly evaluated in terms of zeta potential, size, morphology, and entrapment efficiency. The PMNios achieved a drug loading efficiency of 88%. They exhibited an average size of 298 nm, a polydispersity index of 0.32, and a zeta potential of − 19 mV, indicating the complete stability. SEM and TEM images of the PMNios revealed a spherical morphology. Subsequently, the PMNios were compared with other forms of nano-niosomes, including empty niosomes, non-magnetic niosomes, and non-PEGylated niosomes. The encapsulation of the nano-niosomes with magnetic nanoparticles allows for faster delivery of the encapsulated drugs to the tumor site, while PEGylation improved the stability, bioavailability, and controlled release of the PMNios. Furthermore, the in-vitro effectiveness of various formulations of the PMNios against A549, a lung cancer cell line, demonstrated that the PMNios exhibited appropriate toxicity towards cancer cell lines in the presence of an external magnetic field. Gene expression level of Bcl2 were lower for the PMNios-ART-MET system, whereas the level of Bax were higher than the other group. The PMNios-ART-MET system also demonstrated well internalization into the A549 cells and preponderant endocytosis. These findings underscore the novelty and potential of PMNios as a robust platform for the targeted co-delivery of hydrophilic and hydrophobic drugs, promising a new frontier in cancer therapy by enhancing the therapeutic index and minimizing side effects.

5 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ZMZohreh Mirjafary
Zohreh Mirjafary
MKMahdieh Mohammad Karbasi
Mahdieh Mohammad Karbasi
PHParsa Hesamzadeh
Parsa Hesamzadeh
HSHamid Reza Shaker
Hamid Reza Shaker
AAAsghar Amiri
Asghar Amiri
Hamid SaeidianHamid Saeidian
Hamid Saeidian
A new series of 1,2,3-triazole derivatives 5a–f based on benzothiazole were synthesized by the 1,3-dipolar cycloaddition reaction of S-propargyl mercaptobenzothiazole and α-halo ester/amide in moderate to good yields (47–75%). The structure of all products was characterized by 1H NMR, 13C NMR, and CHN elemental data. This protocol is easy and green and proceeds under mild and green reaction conditions with available starting materials. The structural and electronic analysis and 1H and 13C chemical shifts of the characterized structure of 5e were also calculated by applying the B3LYP/6-31 + G(d, p) level of density functional theory (DFT) method. In the final section, all the synthesized compounds were evaluated for their anti-inflammatory activity by biochemical COX-2 inhibition, antifungal inhibition with CYP51, anti-tuberculosis target protein ENR, DPRE1, pks13, and Thymidylate kinase by molecular docking studies. The ADMET analysis of the molecules 5a–f revealed that 5d and 5a are the most-promising drug-like molecules out of the six synthesized molecules.